Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00084513
Status:
COMPLETED
Last Update Posted:
2010-02-12
First Post:
2004-06-10
Brief Title:
Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2Neu-Expressing Cancer
Sponsor:
Organization:
Fox Chase Cancer Center